Physician profile
Brinton E Coombs
NPI 1639997794
$1,342.70
in general payments reported to CMS, 2019-2025
16 companies · $1,343 in 2025
The $1,343 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,342.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $319.42 | 2025 | Dexcom G6 Transmitter, Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Boehringer Ingelheim Pharmaceuticals, INC. | $164.65 | 2025 | Jardiance, Ofev, Jascayd |
| Lilly USA, LLC | $160.27 | 2025 | Zepbound, Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $149.94 | 2025 | |
| Exact Sciences Corporation | $149.75 | 2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $92.57 | 2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $64.80 | 2025 | |
| Glaxosmithkline, LLC. | $42.50 | 2025 | Shingrix, Arexvy, Bexsero |
| Astellas Pharma US INC | $33.81 | 2025 | Veozah |
| Amgen INC. | $30.16 | 2025 | Repatha, Otezla |
| Inspire Medical Systems, INC. | $28.78 | 2025 | Inspire |
| Si-Bone, INC. | $25.93 | 2025 | |
| Corcept Therapeutics | $25.17 | 2025 | Korlym |
| Pfizer INC. | $21.58 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $18.39 | 2025 | Farxiga |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $14.98 | 2025 | Gvoke Hypopen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brinton Coombs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.